Foghorn Therapeutics Inc. (FHTX) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $50.0K | -94.5% |
| 2024 | $906.0K | -26.0% |
| 2023 | $1.22M | +1.2% |
| 2022 | $1.21M | -63.5% |
| 2021 | $3.31M | -79.5% |
| 2020 | $16.18M | +1571.8% |
| 2019 | $968.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $50.0K | -94.5% |
| 2024 | $906.0K | -26.0% |
| 2023 | $1.22M | +1.2% |
| 2022 | $1.21M | -63.5% |
| 2021 | $3.31M | -79.5% |
| 2020 | $16.18M | +1571.8% |
| 2019 | $968.0K | — |